Thus, unraveling the mechanisms in the PI3K-Akt signaling pathway related to altered glial cell function in AD may eventually provide much-needed novel therapeutic targets and treatment strategies for neurodegenerative diseases. This evidence concerns the gene PIK3CG and neurodegenerative disease.